Nodular Lymphocyte Predominant Hodgkin Lymphoma, Intrapelvic Lymph Nodes (C81.06)

Name of the Condition

• Common Name: Nodular Lymphocyte Predominant Hodgkin Lymphoma, Intrapelvic Lymph Nodes
• Medical Terms: NLP Hodgkin Lymphoma, Lymphocyte-Predominant Hodgkin Lymphoma

Summary

Nodular lymphocyte predominant Hodgkin lymphoma (NLP Hodgkin lymphoma) is a rare subtype of Hodgkin lymphoma that originates in the lymphatic system. It is characterized by the presence of large, abnormal cells known as lymphocyte-predominant (LP) cells, which are distinct from the Reed-Sternberg cells seen in other Hodgkin lymphoma subtypes. The disease typically involves lymph nodes and may spread to other lymphoid tissues or organs. NLP Hodgkin lymphoma tends to have a more indolent course compared to other subtypes, with a higher likelihood of late relapses.

Causes

The exact cause of NLP Hodgkin lymphoma is not fully understood, but it is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is rarely associated with NLP Hodgkin lymphoma. Research suggests that alterations in the B-cell receptor signaling pathway and other genetic abnormalities may play a role in its development.

Risk Factors

• Age: Most commonly diagnosed in adults, with a peak incidence in the 30-50 age range.
• Gender: Slightly more prevalent in males.
• Family history: A small increased risk may be associated with a family history of lymphoma.
• Immune system: Conditions that weaken the immune system may slightly elevate risk.

Symptoms

Symptoms may include painless swelling of lymph nodes in the intrapelvic region, fatigue, unexplained weight loss, fever, or night sweats. Some patients may experience abdominal discomfort or pelvic pressure due to enlarged lymph nodes.

Diagnosis

Diagnosis typically involves a biopsy of the affected lymph node to examine cellular characteristics. Imaging studies, such as CT scans or PET scans, may be used to assess the extent of disease. Blood tests and bone marrow biopsies may also be performed to evaluate overall health and rule out other conditions.

Treatment Options

Treatment often includes radiation therapy for localized disease or chemotherapy for more extensive involvement. Immunotherapy or targeted therapy may be considered in some cases. Treatment plans are individualized based on the stage and specific characteristics of the disease.

Prognosis and Follow-Up

NLP Hodgkin lymphoma generally has a favorable prognosis, especially when diagnosed at an early stage. However, late relapses can occur, necessitating long-term follow-up. Regular monitoring with physical exams and imaging may be recommended to detect recurrence.

Complications

Potential complications include disease recurrence, transformation to a more aggressive lymphoma, or side effects from treatment such as fatigue, infection risk, or organ damage. Long-term survivors may face secondary health issues related to prior therapies.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet and regular exercise, may support overall well-being during and after treatment. Avoiding known carcinogens and managing stress can also be beneficial. There are no specific preventive measures for this condition.

When to Seek Professional Help

Seek medical attention if you experience persistent, unexplained lymph node swelling, unexplained weight loss, fever, or other concerning symptoms. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Use code C81.06 for nodular lymphocyte predominant Hodgkin lymphoma specifically involving intrapelvic lymph nodes. Ensure documentation clearly specifies the anatomical location to support accurate coding. Review clinical notes for confirmation of the subtype and site to avoid miscoding.